Taken together, our results support that progranulin, mainly derived from macrophages, and LIF, mainly derived from cancer cells, drives pSTAT3+myMAF activation, and inhibition of either progranulin or LIF is sufficient to disrupt their associated pro-metastatic functions. Here, LIF is linked to cancer.